# Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream

> **NCT00193908** · PHASE3 · COMPLETED · sponsor: **Trans Tasman Radiation Oncology Group** · enrollment: 333 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Cavilon (TM) Durable Barrier Cream
- **DRUG:** Sorbolene
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT00193908
- **Lead sponsor:** Trans Tasman Radiation Oncology Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2007-09
- **Final completion:** 2008-10
- **Target enrollment:** 333 (ACTUAL)
- **Last updated:** 2009-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00193908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00193908, "Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00193908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*